Wang Hai-Yun, Wang Guo-Lin, Yu Yong-Hao, Chen Xing-Yun, Wang Ying
Department of Anesthesiology, General Hospital, Tianjin Medical University, Tianjin 300052, China.
Zhonghua Yi Xue Za Zhi. 2009 Jan 6;89(1):54-8.
To investigate whether the infusion of propofol during early reperfusion provides ischemic postconditioning (I-postC) on myocardial ischemia-reperfusion injury in rats.
Sixty adult rats were randomly divided into 5 groups (n = 12 each): sham operation (group S); normal saline (group C); propofol 1 mg/kg (group P1); propofol 2 mg/kg (group P2); propofol 5 mg/kg (group P3). The left anterior descending coronary artery (LAD) was occluded for 60 min and reperfused for 120 min. Normal saline, propofol 1 mg/kg, 2 mg/kg or 5 mg/kg (propofol diluted to 2.5 ml with normal saline equally) were intravenously infused 3 min before reperfusion until 5 min after reperfusion. The heart were obtained for determination of (1) the size of area at risk and infarct size (Evans Blue and TTC staining); (2) expression of Caspase-3 (immunohistochemistry staining); (3) percentage of apoptotic cardiomyocytes (flow cytometry); (4) levels of phosphorylated Akt (Western blot).
Compared with group C [size of area at risk (41.5 +/- 1.0)%, infarct size (45.5 +/- 1.0)%, expression of caspase-3 (5.87 +/- 0.29), percentage of apoptotic cardiomyocytes (26.8 +/- 1.3)%, level of phosphorylated Akt (10.8 +/- 1.9)%], propofol 1 mg/kg and 2 mg/kg significantly reduced the size of area at risk and infarct size [size of area at risk (38.3 +/- 1.0)% and (37.3 +/- 1.2)%; infarct size (33.8 +/- 1.2)% and (30.2 +/- 1.7)%, P < 0.05], inhibited the expression of caspase-3 (1.50 +/- 0.36 and 1.48 +/- 0.30, P < 0.05), decreased the percentage of apoptotic cardiomyocytes [(16.3 +/- 1.2)% and (16.5 +/- 1.0)%, P < 0.05] and promoted the phosphorylation of Akt [(68.7 +/- 4.0)% and (58.3 +/- 2.8)%, P < 0.05].
Propofol 1 mg/kg and 2 mg/kg can provide I-postC to myocardial ischemia-reperfusion injury in rats by activation of Akt pathway.
探讨早期再灌注期间输注丙泊酚是否能对大鼠心肌缺血-再灌注损伤产生缺血后处理(I-postC)作用。
将60只成年大鼠随机分为5组(每组n = 12):假手术组(S组);生理盐水组(C组);丙泊酚1 mg/kg组(P1组);丙泊酚2 mg/kg组(P2组);丙泊酚5 mg/kg组(P3组)。结扎左冠状动脉前降支60分钟,再灌注120分钟。在再灌注前3分钟至再灌注后5分钟,分别静脉输注生理盐水、丙泊酚1 mg/kg、2 mg/kg或5 mg/kg(丙泊酚用生理盐水等体积稀释至2.5 ml)。取心脏用于测定:(1)危险区面积和梗死面积大小(伊文思蓝和TTC染色);(2)Caspase-3表达(免疫组织化学染色);(3)凋亡心肌细胞百分比(流式细胞术);(4)磷酸化Akt水平(蛋白质印迹法)。
与C组相比[危险区面积大小(41.5±1.0)%,梗死面积大小(45.5±1.0)%,Caspase-3表达(5.87±0.29),凋亡心肌细胞百分比(26.8±1.3)%,磷酸化Akt水平(10.8±1.9)%],丙泊酚1 mg/kg和2 mg/kg组显著减小了危险区面积和梗死面积大小[危险区面积大小(38.3±1.0)%和(37.3±1.2)%;梗死面积大小(33.8±1.2)%和(30.2±1.7)%,P < 0.05],抑制了Caspase-3表达(1.50±0.36和1.48±0.30,P < 0.05),降低了凋亡心肌细胞百分比[(16.3±1.2)%和(16.5±1.0)%,P < 0.05],并促进了Akt磷酸化[(68.7±4.0)%和(58.3±2.8)%,P < 0.05]。
丙泊酚1 mg/kg和2 mg/kg可通过激活Akt通路对大鼠心肌缺血-再灌注损伤产生I-postC作用。